German Diabetes Stakeholders Like The New Talk On Strategy And Reimbursement, But Where's The Action?
Executive Summary
The up-to-10 million diabetics in Germany could benefit from a more optimal combination of digital tools and conventional case to maintain glucose control, say local IVD companies. But the industry is still waiting on the promised National Diabetes Strategy, while the government talks about more reimbursement support for innovation.